Pharmalot Newsletter
Examining the pharmaceutical sector, from research and development to the pharmacy shelf.
Outlet metrics
Global
#21558
United States
#4823
Health/Health
#104
Articles
-
2 days ago |
statnews.com | John Wilkerson
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. After making a brief visit to the hospital due to feeling lightheaded, Senate Minority Leader Chuck Schumer (D-NY) gave this sage advice: drink some water and stay out of the heat.
-
2 days ago |
statnews.com | John Wilkerson |Daniel Payne
The Senate parliamentarian struck down several major health care measures in Republicans’ tax bill, including Medicaid changes that the GOP was counting on to help pay for President Trump’s tax cuts. The parliamentarian’s decision is a major challenge to Republicans’ plans to reap savings from the Medicaid program and could lead lawmakers to look for new savings across federal programs. It may make it more difficult for them to pass the bill ahead of Trump’s July 4 deadline.
-
2 days ago |
statnews.com | Adam Feuerstein
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Insmed CEO Will Lewis keeps a newspaper story from 2014 framed on the wall of his office. The headline reads, “Insmed joins the biotech trash heap.”If you’re wondering, I didn’t write that story, although I could have.
-
3 days ago |
statnews.com | Elaine Chen
How did Novo Nordisk get to the position it’s in now — with its stock halved over the past year and the company widely seen as trailing Eli Lilly in the weight loss market it once led? “I’m not sure I fully accept the premise of the question,” Martin Lange, Novo’s head of development, responded. At the American Diabetes Association meeting in Chicago this week, Novo executives argued the company is not falling behind.
-
3 days ago |
statnews.com | Jason Mast
A leader of a federal vaccine advisory committee said Wednesday that the panel would start a review of long-approved vaccines, as well as the cumulative effect of the shots given to children and adolescents. Martin Kulldorff, named co-chair of the Centers for Disease Control and Prevention’s vaccine advisory committee after health secretary Robert F.
Pharmalot Newsletter journalists
Contact details
Address
123 Example Street
City, Country 12345
Email Patterns
No sites or socials found.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →